Literature DB >> 14621777

Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia.

I R Marino1, V P Scantlebury, O Bronsther, S Iwatsuki, T E Starzl.   

Abstract

Extensive hepatocellular adenomatosis (HA) and focal nodular hyperplasia (FNH) represent a proliferation of hepatic cells that occurs most frequently in women. These lesions are uncommon in the pediatric age group, accounting for 2% of pediatric hepatic tumors, and are extremely rare in males. The etiology of HA and FNH has been correlated with the use of oral contraceptives. We report to the best of our knowledge the first series of patients treated with OLTx for HA and FNH (five cases). All these patients had lesions involving at least 90% of the hepatic parenchyma and all underwent major hepatic surgery before OLTx because of life threatening complications. One patient died in the immediate postoperative period following retransplantation for primary non-function of the first OLTx. Four out of five patients are currently alive from 4.1 to 9.6 years after OLTx. Our results justify the use of OLTx for symptomatic patients with HA and FNH who cannot be treated with conventional hepatic resections.

Entities:  

Mesh:

Year:  1992        PMID: 14621777      PMCID: PMC2993572          DOI: 10.1007/978-3-642-77423-2_64

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  26 in total

Review 1.  Type I glycogen storage disease: a metabolic basis for advances in treatment.

Authors:  H L Greene; A E Slonim; I M Burr
Journal:  Adv Pediatr       Date:  1979

Review 2.  Hepatic tumors in the pediatric age group: a distinctive clinicopathologic spectrum.

Authors:  L P Dehner
Journal:  Perspect Pediatr Pathol       Date:  1978

3.  Focal nodular hyperplasia of the liver and oral contraceptives.

Authors:  R Kinch; J Lough
Journal:  Am J Obstet Gynecol       Date:  1978-12-01       Impact factor: 8.661

4.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

5.  Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver.

Authors:  F Zangeneh; G A Limbeck; B I Brown; J R Emch; M M Arcasoy; V E Goldenberg; V C Kelley
Journal:  J Pediatr       Date:  1969-01       Impact factor: 4.406

6.  Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases.

Authors:  K G Ishak; P R Glunz
Journal:  Cancer       Date:  1967-03       Impact factor: 6.860

7.  Portal diversion for the treatment of glycogen storage disease in humans.

Authors:  T E Starzl; C W Putnam; K A Porter; C G Halgrimson; J Corman; B I Brown; R W Gotlin; D O Rodgerson; H L Greene
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

8.  Excisional treatment of cavernous hemangioma of the liver.

Authors:  T E Starzl; L J Koep; R Weil; R H Fennell; S Iwatsuki; T Kano; M L Johnson
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

9.  Regression of liver cell adenomas associated with oral contraceptives.

Authors:  H A Edmondson; T B Reynolds; B Henderson; B Benton
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

10.  Hepatic adenomata with type 1 glycogen storage disease.

Authors:  R R Howell; R E Stevenson; Y Ben-Menachem; R L Phyliky; D H Berry
Journal:  JAMA       Date:  1976-09-27       Impact factor: 56.272

View more
  8 in total

Review 1.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

2.  Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA.

Authors:  Ignazio Roberto Marino; Thomas E Starzl
Journal:  Kusuri No Chishiki       Date:  1995

Review 3.  Management of hepatic adenomatosis.

Authors:  Manish Thapar; Oleg Grapp; Constantine Fisher
Journal:  Curr Gastroenterol Rep       Date:  2015-03

4.  Orthotopic liver transplantation for giant liver haemangioma: A case report.

Authors:  Undine G Lange; Julian N Bucher; Markus B Schoenberg; Christian Benzing; Moritz Schmelzle; Tanja Gradistanac; Steffen Strocka; Hans-Michael Hau; Michael Bartels
Journal:  World J Transplant       Date:  2015-12-24

5.  Liver Transplantation for Hepatic Adenoma: A UNOS Database Analysis and Systematic Review of the Literature.

Authors:  Ioannis A Ziogas; Panagiotis T Tasoudis; Nikolaos Serifis; Sophoclis P Alexopoulos; Martin I Montenovo; Alexandra Shingina
Journal:  Transplant Direct       Date:  2022-01-05

6.  Case Report: Hepatic Adenomatosis in a Patient With Prader-Willi Syndrome.

Authors:  Hajar Dauleh; Ali Soliman; Basma Haris; Amal Khalifa; Noor Al Khori; Khalid Hussain
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

7.  Living donor liver transplantation for idiopathic portal hypertension with focal nodular hyperplasia.

Authors:  Yoshiaki Tanji; Kenei Furukawa; Yosuke Igarashi; Mitsuru Yanagaki; Koichiro Haruki; Yoshihiro Shirai; Tomohiko Taniai; Takeshi Gocho; Norimitsu Okui; Toru Ikegami
Journal:  Surg Case Rep       Date:  2022-04-21

8.  Benign hepatocellular tumors in children: focal nodular hyperplasia and hepatocellular adenoma.

Authors:  Stéphanie Franchi-Abella; Sophie Branchereau
Journal:  Int J Hepatol       Date:  2013-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.